Pembrolizumab Plus Chemotherapy for Metastatic Squamous Non‒Small-Cell Lung Cancer: Long-Term Follow-Up of the KEYNOTE-407 China Study

JTO Clinical and Research Reports · Published 2026-06-01 · DOI 10.1016/j.jtocrr.2026.101041

Free full text

Authors (18)

Jie Hu, Ying Cheng, Li Zhang, Donglin Wang, ChengPing Hu, Jianying Zhou, Lin Wu, Lejie Cao, Jiwei Liu, Helong Zhang, Hong Sun, Ziping Wang, Hongjun Gao, Yuping Sun, Xiaohan Hu, Erin Jensen, Kumar Rajagopalan, Luis Paz-Ares

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hu, J., Cheng, Y., Zhang, L., et al. (2026). Pembrolizumab Plus Chemotherapy for Metastatic Squamous Non‒Small-Cell Lung Cancer: Long-Term Follow-Up of the KEYNOTE-407 China Study. JTO Clinical and Research Reports. https://doi.org/10.1016/j.jtocrr.2026.101041

Related articles

• Tarlatamab in Relapsed Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: A Case with Comparative DLL3 Expression Analysis · JTO Clinical and Research Reports · 2026 · Same journal
• Lung Cancer Screening Recommendations in the Elderly: International Society for Geriatric Oncology (SIOG) Consensus Statement · JTO Clinical and Research Reports · 2026 · Same journal
• Comparison of long-term survival between nivolumab plus ipilimumab and nivolumab plus ipilimumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study · JTO Clinical and Research Reports · 2026 · Same journal
• Concurrent Hypertrophic Osteoarthropathy and Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis in a Patient With NSCLC: A Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Lung Cancer Screening Eligible Population from 2000 to 2050 in Argentina. A simulation study brief report · JTO Clinical and Research Reports · 2026 · Same journal
• Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Safety and Efficacy of Bronchoscopic Pulsed Electric Field Ablation for Lung Cancer and Metastases · JTO Clinical and Research Reports · 2026 · Same journal
• Multi-Institutional Integration of Circulating miRNAs and Protein Tumor Markers for Early Lung Cancer Detection · JTO Clinical and Research Reports · 2026 · Same journal
• Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study · JTO Clinical and Research Reports · 2026 · Same journal